Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Kopinski, K. Sladek, J. Kus, J. Chorostowska-Wynimko, J. Soja, A. Szlubowski, G. Pinis, L. Adamek, K. Lewandowska, M. Duplaga, J. Szczeklik (Bydgoszcz, Krakow, Warszawa, Poland). Flow cytometry (FC) in examination of broncholaveolar lavage (BAL) in interstitial lung diseases (ILD). Presentation of 14 years‘ experience. Eur Respir J 2007; 30: Suppl. 51, 4487

Member's Comments

No comment yet.

Related content which might interest you: Flow cytometry (FC) applied to bronchoalveolar lavage lymphocyte (L-BAL) analyses as auxiliary diagnostic tool in interstitial lung diseases (ILD) Source: Eur Respir J 2003; 22: Suppl. 45, 226s Year: 2003 Alveolar lymphocytes (AL) in healthy individuals are mostly effector T cells. The flow cytometry (FC) lesson for interstitial lung diseases (ILD) evaluation Source: International Congress 2016 – ILD pathogenesis Year: 2016 Induced sputum (IS) in patients with interstitial lung disease (ILD) – comparison with bronchoalveolar lavage (BAL) Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease Year: 2007 Immunocytological study of bronchioloalveolar lavage (BAL) in interstitial lung diseases (ILD) diagnosis Source: International Congress 2018 – Bronchoscopy and transthoracic ultrasound Year: 2018 A comparison of T lymphocytes (TLs) subpopulations in lung tissue and in bronchoalveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2004; 24: Suppl. 48, 43s Year: 2004 Correlation between cellularity of bronchoalveolar lavage (BAL) and parameters of lung function (LF) in patients with sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 180s Year: 2003 The diagnostic value of bronchoalvolar lavage (BAL) in the diagnosis of peripheral lung cancer (PLC) Source: Eur Respir J 2003; 22: Suppl. 45, 253s Year: 2003 The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls Source: International Congress 2014 – ILDs 4 Year: 2014 Studies on interferon-gamma (IFN-γ) expression in lower airways of patients with idiopathic pulmonary fibrosis (IPF), sarcoidosis and pneumoconioses. Lower IFN-γ levels in bronchoalveolar lavage (BAL) supernatants of IPF subgroup with decrease Source: Eur Respir J 2007; 30: Suppl. 51, 121s Year: 2007 The role of the combined assessment of the bronchoalveolar lavage (BAL) and radiological profile in the diagnosis of chronic eosinophilic pneumonia (CEP) Source: Annual Congress 2013 –Modern approach to various clinical settings Year: 2013 Mechanisms of impaired immune surveillance in lower airways of smokers. Data from bronchoalveolar lavage (BAL) harvested in selected interstitial lung diseases (ILDs) and control group Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011 Alveolar lymphocytes (AL) produce interleukin 27 (IL27), antigen presenting cell-secreted cytokine. Increased expression of IL27 in bronchoalveolar lavage (BAL) of pulmonary sarcoidosis (PS) patients Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Studies on bronchoalveolar lavage lymphocytes (L-BAL) apoptosis in pulmonary sarcoidosis (PS) and silicosis Source: Eur Respir J 2003; 22: Suppl. 45, 377s Year: 2003 Flow cytometry vs. immunohistochemistry in determining CD4+/CD8+ cell ratio in BAL fluid from patients with interstitial lung diseases Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 Fibrocytes are detected in bronchoalveolar lavage (BAL) fluid in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011 Transbronchial lung cryobiopsy (TBLC) and bronchoalveolar lavage (BAL) in diagnosis of Intersticial Lung Diseases (ILD) Source: International Congress 2019 – Interventional pulmonology techniques: targeting selective lung tissue Year: 2019 The impact of age on broncholaveolar lavage (BAL) cytoimmunological results in nonsmoking patients with interstitial lung diseases (ILD) and in healthy volunteers Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 Prognostic value of cytokeratin 19 in bronchoalveolar lavage (BAL) in patients with acute lung injury (ALI) Source: Eur Respir J 2002; 20: Suppl. 38, 599s Year: 2002 Induced sputum versus bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2003; 22: Suppl. 45, 227s Year: 2003 Bronchoalveolar lavage fluid (BALF) phospholipids (PL) and tumor necrosis factor-α (TNF-α) produced by alveolar macrophages (AM) can be used for predicting the course of sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 468s Year: 2002